PRJDB7713: Age associated transcriptome analysis in 5 tissues of zebrafish
Gene Symbol | Gene ID | Gene Info |
---|---|---|
fev
|
ENSDARG00000009242 | FEV transcription factor, ETS family member |
fli1a
|
ENSDARG00000054632 | Fli-1 proto-oncogene, ETS transcription factor a |
erg
|
ENSDARG00000077304 | ETS transcription factor ERG |
etv2
|
ENSDARG00000053868 | ETS variant transcription factor 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
etv2 | dr11_v1_chr16_-_42013858_42013858 | 0.47 | 2.0e-06 | Click! |
erg | dr11_v1_chr10_-_167782_167782 | 0.42 | 3.0e-05 | Click! |
fli1a | dr11_v1_chr18_+_48428126_48428126 | 0.39 | 9.7e-05 | Click! |
fev | dr11_v1_chr9_-_11549379_11549379 | 0.30 | 3.7e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr22_-_23668356 | 32.09 |
ENSDART00000167106
ENSDART00000159622 ENSDART00000163228 |
cfh
|
complement factor H |
chr23_+_44611864 | 23.29 |
ENSDART00000145905
ENSDART00000132361 |
eno3
|
enolase 3, (beta, muscle) |
chr15_+_20239141 | 17.63 |
ENSDART00000101152
ENSDART00000152473 |
spint2
|
serine peptidase inhibitor, Kunitz type, 2 |
chr6_+_112579 | 16.78 |
ENSDART00000034505
|
ap1m2
|
adaptor-related protein complex 1, mu 2 subunit |
chr18_-_49286381 | 16.13 |
ENSDART00000174248
ENSDART00000174038 |
si:zfos-464b6.2
|
si:zfos-464b6.2 |
chr21_+_25765734 | 15.74 |
ENSDART00000021664
|
cldnb
|
claudin b |
chr24_-_38083378 | 14.05 |
ENSDART00000056381
|
crp2
|
C-reactive protein 2 |
chr15_-_3277635 | 14.05 |
ENSDART00000189094
|
slc25a15a
|
solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 15a |
chr17_-_2039511 | 13.78 |
ENSDART00000160223
|
spint1a
|
serine peptidase inhibitor, Kunitz type 1 a |
chr1_-_37383539 | 13.45 |
ENSDART00000127579
|
scpp1
|
secretory calcium-binding phosphoprotein 1 |
chr1_-_59348118 | 13.35 |
ENSDART00000170901
|
cyp3a65
|
cytochrome P450, family 3, subfamily A, polypeptide 65 |
chr5_-_69948099 | 13.34 |
ENSDART00000034639
ENSDART00000191111 |
ugt2a4
|
UDP glucuronosyltransferase 2 family, polypeptide A4 |
chr6_+_21202639 | 13.26 |
ENSDART00000083126
|
cidec
|
cell death-inducing DFFA-like effector c |
chr16_+_38201840 | 13.16 |
ENSDART00000044971
|
myo1eb
|
myosin IE, b |
chr15_+_36457888 | 13.08 |
ENSDART00000155100
|
si:dkey-262k9.2
|
si:dkey-262k9.2 |
chr7_+_67467702 | 12.90 |
ENSDART00000168460
ENSDART00000170322 |
rpl13
|
ribosomal protein L13 |
chr21_+_22985078 | 12.65 |
ENSDART00000156491
|
lpar6b
|
lysophosphatidic acid receptor 6b |
chr6_-_10233538 | 12.25 |
ENSDART00000182004
ENSDART00000149237 ENSDART00000148876 |
xirp2a
|
xin actin binding repeat containing 2a |
chr7_+_19482084 | 11.98 |
ENSDART00000173873
|
si:ch211-212k18.7
|
si:ch211-212k18.7 |
chr22_+_5687615 | 11.83 |
ENSDART00000133241
ENSDART00000019854 ENSDART00000138102 |
dnase1l4.2
|
deoxyribonuclease 1 like 4, tandem duplicate 2 |
chr8_-_19280856 | 11.79 |
ENSDART00000100473
|
zgc:77486
|
zgc:77486 |
chr19_-_48312109 | 11.74 |
ENSDART00000161103
|
si:ch73-359m17.9
|
si:ch73-359m17.9 |
chr14_+_6946482 | 11.70 |
ENSDART00000061001
|
rack1
|
receptor for activated C kinase 1 |
chr19_+_17385561 | 11.56 |
ENSDART00000141397
ENSDART00000143913 ENSDART00000133626 |
rpl15
|
ribosomal protein L15 |
chr23_+_17865953 | 11.51 |
ENSDART00000014723
ENSDART00000140302 ENSDART00000144800 |
naca
|
nascent polypeptide-associated complex alpha subunit |
chr19_-_15192638 | 11.12 |
ENSDART00000048151
|
phactr4a
|
phosphatase and actin regulator 4a |
chr14_+_20911310 | 10.89 |
ENSDART00000160318
|
lygl2
|
lysozyme g-like 2 |
chr17_-_37395460 | 10.42 |
ENSDART00000148160
ENSDART00000075975 |
crip1
|
cysteine-rich protein 1 |
chr1_-_29658721 | 10.40 |
ENSDART00000132063
|
si:dkey-1h24.6
|
si:dkey-1h24.6 |
chr23_+_17865554 | 10.37 |
ENSDART00000181009
ENSDART00000162822 |
naca
|
nascent polypeptide-associated complex alpha subunit |
chr22_+_997838 | 10.30 |
ENSDART00000149743
|
pparda
|
peroxisome proliferator-activated receptor delta a |
chr16_-_22192006 | 10.11 |
ENSDART00000163338
|
il6r
|
interleukin 6 receptor |
chr16_-_40426837 | 9.84 |
ENSDART00000193690
|
plekhf2
|
pleckstrin homology domain containing, family F (with FYVE domain) member 2 |
chr15_+_34963316 | 9.75 |
ENSDART00000153840
|
si:ch73-95l15.5
|
si:ch73-95l15.5 |
chr15_-_5815006 | 9.69 |
ENSDART00000102459
|
rbp2a
|
retinol binding protein 2a, cellular |
chr20_+_38285671 | 9.67 |
ENSDART00000061432
|
ccl38a.4
|
chemokine (C-C motif) ligand 38, duplicate 4 |
chr12_+_22576404 | 9.63 |
ENSDART00000172053
|
capgb
|
capping protein (actin filament), gelsolin-like b |
chr15_+_15779184 | 9.57 |
ENSDART00000156902
|
si:ch211-33e4.2
|
si:ch211-33e4.2 |
chr14_-_26482096 | 9.56 |
ENSDART00000187280
|
smad5
|
SMAD family member 5 |
chr16_+_11558868 | 9.43 |
ENSDART00000112497
ENSDART00000180445 |
zgc:198329
|
zgc:198329 |
chr19_+_32855139 | 9.38 |
ENSDART00000052082
|
rpl30
|
ribosomal protein L30 |
chr8_+_54284961 | 9.22 |
ENSDART00000122692
|
plxnd1
|
plexin D1 |
chr7_-_51639699 | 9.12 |
ENSDART00000128917
|
rps4x
|
ribosomal protein S4, X-linked |
chr19_-_15192840 | 9.11 |
ENSDART00000151337
|
phactr4a
|
phosphatase and actin regulator 4a |
chr20_+_54290356 | 9.09 |
ENSDART00000173347
|
zp2.2
|
zona pellucida glycoprotein 2, tandem duplicate 2 |
chr11_-_141592 | 9.04 |
ENSDART00000092787
|
cdk4
|
cyclin-dependent kinase 4 |
chr13_-_52089003 | 9.02 |
ENSDART00000187600
|
tmem254
|
transmembrane protein 254 |
chr13_+_30696286 | 8.99 |
ENSDART00000192411
|
cxcl18a.1
|
chemokine (C-X-C motif) ligand 18a, duplicate 1 |
chr10_+_9553935 | 8.89 |
ENSDART00000028855
|
si:ch211-243g18.2
|
si:ch211-243g18.2 |
chr17_-_48936123 | 8.82 |
ENSDART00000024379
|
gnmt
|
glycine N-methyltransferase |
chr3_-_15080226 | 8.78 |
ENSDART00000109818
ENSDART00000139835 |
nme4
|
NME/NM23 nucleoside diphosphate kinase 4 |
chr16_+_3982590 | 8.71 |
ENSDART00000149295
|
zc3h12a
|
zinc finger CCCH-type containing 12A |
chr20_+_54079341 | 8.63 |
ENSDART00000060444
|
rps29
|
ribosomal protein S29 |
chr23_-_41651759 | 8.62 |
ENSDART00000146808
|
si:ch73-184c24.1
|
si:ch73-184c24.1 |
chr14_+_32918172 | 8.62 |
ENSDART00000182867
|
lnx2b
|
ligand of numb-protein X 2b |
chr4_-_992063 | 8.59 |
ENSDART00000181630
ENSDART00000183898 ENSDART00000160902 |
naga
|
N-acetylgalactosaminidase, alpha |
chr24_-_31306724 | 8.45 |
ENSDART00000165399
|
acp5b
|
acid phosphatase 5b, tartrate resistant |
chr7_+_26545502 | 8.41 |
ENSDART00000140528
|
tnk1
|
tyrosine kinase, non-receptor, 1 |
chr21_-_25295087 | 8.32 |
ENSDART00000087910
ENSDART00000147860 |
st14b
|
suppression of tumorigenicity 14 (colon carcinoma) b |
chr1_-_37383741 | 8.21 |
ENSDART00000193155
ENSDART00000191887 ENSDART00000189077 |
scpp1
|
secretory calcium-binding phosphoprotein 1 |
chr1_+_56180416 | 8.19 |
ENSDART00000089358
|
crb3b
|
crumbs homolog 3b |
chr22_-_23748284 | 8.17 |
ENSDART00000162005
|
cfhl2
|
complement factor H like 2 |
chr20_+_54312970 | 8.11 |
ENSDART00000024598
ENSDART00000193172 |
zp2.5
|
zona pellucida glycoprotein 2, tandem duplicate 5 |
chr21_-_233282 | 8.10 |
ENSDART00000157684
|
bxdc2
|
brix domain containing 2 |
chr10_+_38417512 | 7.98 |
ENSDART00000112457
|
samsn1b
|
SAM domain, SH3 domain and nuclear localisation signals 1b |
chr1_+_51615672 | 7.93 |
ENSDART00000165117
|
zgc:165656
|
zgc:165656 |
chr8_+_30709685 | 7.91 |
ENSDART00000133989
|
upb1
|
ureidopropionase, beta |
chr7_+_6652967 | 7.88 |
ENSDART00000102681
|
pnp5a
|
purine nucleoside phosphorylase 5a |
chr14_-_9128919 | 7.87 |
ENSDART00000108641
|
sh2d1ab
|
SH2 domain containing 1A duplicate b |
chr3_+_56574623 | 7.79 |
ENSDART00000130877
|
rac1b
|
Rac family small GTPase 1b |
chr3_-_33030727 | 7.79 |
ENSDART00000157591
ENSDART00000193200 |
CT583642.1
|
|
chr13_+_228045 | 7.78 |
ENSDART00000161091
|
zgc:64201
|
zgc:64201 |
chr24_+_23959487 | 7.76 |
ENSDART00000080487
|
hgd
|
homogentisate 1,2-dioxygenase |
chr21_-_28439596 | 7.75 |
ENSDART00000089980
ENSDART00000132844 |
rasgrp2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr5_+_26795773 | 7.75 |
ENSDART00000145631
|
tcn2
|
transcobalamin II |
chr13_-_42749916 | 7.73 |
ENSDART00000140019
|
capn2a
|
calpain 2, (m/II) large subunit a |
chr19_-_40192249 | 7.71 |
ENSDART00000051972
|
grn1
|
granulin 1 |
chr8_-_14554785 | 7.70 |
ENSDART00000057645
|
qsox1
|
quiescin Q6 sulfhydryl oxidase 1 |
chr2_+_22495274 | 7.69 |
ENSDART00000167915
|
lrrc8da
|
leucine rich repeat containing 8 VRAC subunit Da |
chr14_-_12390724 | 7.69 |
ENSDART00000131343
|
magt1
|
magnesium transporter 1 |
chr25_-_30357027 | 7.62 |
ENSDART00000171137
|
pdia3
|
protein disulfide isomerase family A, member 3 |
chr3_+_32416948 | 7.60 |
ENSDART00000157324
ENSDART00000154267 ENSDART00000186094 ENSDART00000155860 ENSDART00000156986 |
prrg2
|
proline rich Gla (G-carboxyglutamic acid) 2 |
chr12_-_28983584 | 7.56 |
ENSDART00000112374
|
zgc:171713
|
zgc:171713 |
chr9_-_56232296 | 7.54 |
ENSDART00000149554
|
rpl31
|
ribosomal protein L31 |
chr21_+_30794351 | 7.53 |
ENSDART00000139486
|
zgc:158225
|
zgc:158225 |
chr1_-_45157243 | 7.52 |
ENSDART00000131882
|
mucms1
|
mucin, multiple PTS and SEA group, member 1 |
chr19_+_43297546 | 7.49 |
ENSDART00000168002
|
laptm5
|
lysosomal protein transmembrane 5 |
chr6_-_49063085 | 7.48 |
ENSDART00000156124
|
si:ch211-105j21.9
|
si:ch211-105j21.9 |
chr21_+_6556635 | 7.46 |
ENSDART00000139598
|
col5a1
|
procollagen, type V, alpha 1 |
chr16_-_9802449 | 7.41 |
ENSDART00000081208
|
tapbpl
|
TAP binding protein (tapasin)-like |
chr5_-_29531948 | 7.40 |
ENSDART00000098360
|
arrdc1a
|
arrestin domain containing 1a |
chr20_+_38276690 | 7.39 |
ENSDART00000061437
|
ccl38.6
|
chemokine (C-C motif) ligand 38, duplicate 6 |
chr16_+_11818126 | 7.37 |
ENSDART00000145727
|
cxcr3.2
|
chemokine (C-X-C motif) receptor 3, tandem duplicate 2 |
chr21_-_5056812 | 7.37 |
ENSDART00000139713
ENSDART00000140859 |
zgc:77838
|
zgc:77838 |
chr16_-_50897887 | 7.34 |
ENSDART00000156985
|
si:ch73-90p23.1
|
si:ch73-90p23.1 |
chr10_+_41199660 | 7.33 |
ENSDART00000125314
|
adrb3b
|
adrenoceptor beta 3b |
chr23_+_44374041 | 7.29 |
ENSDART00000136056
|
ephb4b
|
eph receptor B4b |
chr20_+_54309148 | 7.25 |
ENSDART00000099360
|
zp2.1
|
zona pellucida glycoprotein 2, tandem duplicate 1 |
chr14_+_52440161 | 7.17 |
ENSDART00000168437
|
b4galt1l
|
DP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1, like |
chr24_-_10014512 | 7.16 |
ENSDART00000124341
ENSDART00000191630 |
zgc:171474
|
zgc:171474 |
chr12_-_4243268 | 7.14 |
ENSDART00000131275
|
zgc:92313
|
zgc:92313 |
chr8_+_3379815 | 7.11 |
ENSDART00000155995
|
FUT9 (1 of many)
|
zgc:136963 |
chr12_+_47663419 | 7.07 |
ENSDART00000171932
|
HHEX
|
hematopoietically expressed homeobox |
chr13_-_36582341 | 7.07 |
ENSDART00000137335
|
lgals3a
|
lectin, galactoside binding soluble 3a |
chr5_+_37087583 | 7.06 |
ENSDART00000049900
|
tagln2
|
transgelin 2 |
chr13_-_34858500 | 7.04 |
ENSDART00000184843
|
sptlc3
|
serine palmitoyltransferase, long chain base subunit 3 |
chr9_+_2762270 | 6.98 |
ENSDART00000123342
ENSDART00000001795 ENSDART00000177563 |
sp3a
|
sp3a transcription factor |
chr21_+_27448856 | 6.96 |
ENSDART00000100784
|
cfbl
|
complement factor b-like |
chr22_-_26353916 | 6.96 |
ENSDART00000077958
|
capn2b
|
calpain 2, (m/II) large subunit b |
chr7_+_27041315 | 6.95 |
ENSDART00000052730
|
rps13
|
ribosomal protein S13 |
chr19_-_40199081 | 6.94 |
ENSDART00000051970
ENSDART00000151079 |
grn2
|
granulin 2 |
chr5_+_26795465 | 6.90 |
ENSDART00000053001
|
tcn2
|
transcobalamin II |
chr13_-_280827 | 6.90 |
ENSDART00000144819
|
slc30a6
|
solute carrier family 30 (zinc transporter), member 6 |
chr20_+_54299419 | 6.85 |
ENSDART00000056089
ENSDART00000193107 |
si:zfos-1505d6.3
|
si:zfos-1505d6.3 |
chr3_-_61116258 | 6.84 |
ENSDART00000009194
ENSDART00000156978 |
aimp2
|
aminoacyl tRNA synthetase complex-interacting multifunctional protein 2 |
chr7_+_20563305 | 6.83 |
ENSDART00000169661
|
si:dkey-19b23.10
|
si:dkey-19b23.10 |
chr3_-_40528333 | 6.82 |
ENSDART00000193047
|
actb2
|
actin, beta 2 |
chr15_+_17251191 | 6.77 |
ENSDART00000156587
|
si:ch73-223p23.2
|
si:ch73-223p23.2 |
chr9_+_13999620 | 6.75 |
ENSDART00000143229
|
cd28l
|
cd28-like molecule |
chr16_+_26774182 | 6.67 |
ENSDART00000042895
|
cdh17
|
cadherin 17, LI cadherin (liver-intestine) |
chr3_+_22377312 | 6.66 |
ENSDART00000155597
|
arhgap27l
|
Rho GTPase activating protein 27, like |
chr4_+_7677318 | 6.64 |
ENSDART00000149218
|
elk3
|
ELK3, ETS-domain protein |
chr9_+_24088062 | 6.63 |
ENSDART00000126198
|
lrrfip1a
|
leucine rich repeat (in FLII) interacting protein 1a |
chr14_-_40797117 | 6.61 |
ENSDART00000122369
|
elf1
|
E74-like ETS transcription factor 1 |
chr14_+_32918484 | 6.59 |
ENSDART00000105721
|
lnx2b
|
ligand of numb-protein X 2b |
chr20_+_54304800 | 6.54 |
ENSDART00000121661
|
zp2.6
|
zona pellucida glycoprotein 2, tandem duplicate 6 |
chr11_+_8129536 | 6.52 |
ENSDART00000158112
ENSDART00000011183 |
prkacba
|
protein kinase, cAMP-dependent, catalytic, beta a |
chr8_-_42594380 | 6.50 |
ENSDART00000140126
ENSDART00000135238 ENSDART00000192764 |
dok2
|
docking protein 2 |
chr15_-_2652640 | 6.50 |
ENSDART00000146094
|
cldnf
|
claudin f |
chr17_-_21368775 | 6.49 |
ENSDART00000058027
|
shtn1
|
shootin 1 |
chr23_+_26142807 | 6.40 |
ENSDART00000158878
|
ptpn22
|
protein tyrosine phosphatase, non-receptor type 22 |
chr21_+_45839917 | 6.39 |
ENSDART00000189305
|
faxdc2
|
fatty acid hydroxylase domain containing 2 |
chr9_+_21165017 | 6.39 |
ENSDART00000145933
ENSDART00000142985 |
si:rp71-68n21.9
|
si:rp71-68n21.9 |
chr11_-_16975190 | 6.34 |
ENSDART00000122222
|
suclg2
|
succinate-CoA ligase, GDP-forming, beta subunit |
chr16_+_26777473 | 6.32 |
ENSDART00000188870
|
cdh17
|
cadherin 17, LI cadherin (liver-intestine) |
chr19_+_48176745 | 6.26 |
ENSDART00000164963
|
prdm1b
|
PR domain containing 1b, with ZNF domain |
chr21_+_45685757 | 6.25 |
ENSDART00000160530
|
sec24a
|
SEC24 homolog A, COPII coat complex component |
chr1_-_8020589 | 6.24 |
ENSDART00000143881
|
si:dkeyp-9d4.2
|
si:dkeyp-9d4.2 |
chr18_+_3037998 | 6.24 |
ENSDART00000185844
ENSDART00000162657 |
rps3
|
ribosomal protein S3 |
chr14_-_12391506 | 6.20 |
ENSDART00000080864
|
magt1
|
magnesium transporter 1 |
chr2_-_42492445 | 6.20 |
ENSDART00000139929
|
esyt2a
|
extended synaptotagmin-like protein 2a |
chr1_+_49510209 | 6.18 |
ENSDART00000052998
|
si:dkeyp-80c12.4
|
si:dkeyp-80c12.4 |
chr3_+_53240562 | 6.16 |
ENSDART00000031234
|
stxbp2
|
syntaxin binding protein 2 |
chr8_+_8643901 | 6.15 |
ENSDART00000142076
ENSDART00000075624 |
usp11
|
ubiquitin specific peptidase 11 |
chr23_+_27675581 | 6.09 |
ENSDART00000127198
|
rps26
|
ribosomal protein S26 |
chr18_-_6982499 | 6.05 |
ENSDART00000101525
|
si:dkey-266m15.6
|
si:dkey-266m15.6 |
chr1_-_56213723 | 6.04 |
ENSDART00000142505
ENSDART00000137237 |
si:dkey-76b14.2
|
si:dkey-76b14.2 |
chr2_+_16652238 | 6.03 |
ENSDART00000091351
|
gk5
|
glycerol kinase 5 (putative) |
chr6_+_103361 | 6.02 |
ENSDART00000151899
|
ldlrb
|
low density lipoprotein receptor b |
chr16_-_13818061 | 6.02 |
ENSDART00000132982
ENSDART00000144856 |
leng9
|
leukocyte receptor cluster (LRC) member 9 |
chr7_+_1045637 | 5.99 |
ENSDART00000111531
|
epdl1
|
ependymin-like 1 |
chr8_-_17997845 | 5.98 |
ENSDART00000121660
|
acot11b
|
acyl-CoA thioesterase 11b |
chr4_+_12966640 | 5.96 |
ENSDART00000113357
|
vhll
|
von Hippel-Lindau tumor suppressor like |
chr21_-_45840341 | 5.94 |
ENSDART00000006942
|
irf1b
|
interferon regulatory factor 1b |
chr23_+_1078072 | 5.92 |
ENSDART00000159263
ENSDART00000053527 |
slc34a2b
|
solute carrier family 34 (type II sodium/phosphate cotransporter), member 2b |
chr24_-_9997948 | 5.87 |
ENSDART00000136274
|
si:ch211-146l10.7
|
si:ch211-146l10.7 |
chr20_+_54295213 | 5.86 |
ENSDART00000074085
|
zp2.3
|
zona pellucida glycoprotein 2, tandem duplicate 3 |
chr3_+_41714966 | 5.86 |
ENSDART00000155440
|
eif3ba
|
eukaryotic translation initiation factor 3, subunit Ba |
chr4_-_14649158 | 5.85 |
ENSDART00000145737
|
si:dkey-183c2.4
|
si:dkey-183c2.4 |
chr16_-_39570832 | 5.83 |
ENSDART00000039832
|
tgfbr2b
|
transforming growth factor beta receptor 2b |
chr1_-_44484 | 5.82 |
ENSDART00000171547
ENSDART00000164075 ENSDART00000168091 |
tmem39a
|
transmembrane protein 39A |
chr17_+_33453689 | 5.81 |
ENSDART00000156894
|
rin3
|
Ras and Rab interactor 3 |
chr22_+_5478353 | 5.80 |
ENSDART00000160596
|
tppp
|
tubulin polymerization promoting protein |
chr15_-_34878388 | 5.80 |
ENSDART00000154094
|
mgat1a
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase a |
chr18_+_10926197 | 5.78 |
ENSDART00000192387
|
ttc38
|
tetratricopeptide repeat domain 38 |
chr10_-_15849027 | 5.75 |
ENSDART00000184682
|
tjp2a
|
tight junction protein 2a (zona occludens 2) |
chr9_-_16062938 | 5.74 |
ENSDART00000099479
|
crfb4
|
cytokine receptor family member b4 |
chr2_-_37862380 | 5.74 |
ENSDART00000186005
|
si:ch211-284o19.8
|
si:ch211-284o19.8 |
chr3_+_34877066 | 5.67 |
ENSDART00000161963
|
itga3a
|
integrin, alpha 3a |
chr1_+_36674584 | 5.65 |
ENSDART00000186772
ENSDART00000192274 |
ednraa
|
endothelin receptor type Aa |
chr3_+_3545825 | 5.65 |
ENSDART00000109060
|
CR589947.1
|
|
chr16_+_35401543 | 5.63 |
ENSDART00000171608
|
rab42b
|
RAB42, member RAS oncogene family |
chr1_-_18848955 | 5.63 |
ENSDART00000109294
ENSDART00000146410 |
zgc:195282
|
zgc:195282 |
chr20_-_26383368 | 5.62 |
ENSDART00000024518
ENSDART00000087844 |
esr1
|
estrogen receptor 1 |
chr8_+_20440297 | 5.62 |
ENSDART00000189486
|
mknk2b
|
MAP kinase interacting serine/threonine kinase 2b |
chr25_+_5015019 | 5.61 |
ENSDART00000127600
|
hdac10
|
histone deacetylase 10 |
chr16_+_40563533 | 5.57 |
ENSDART00000190368
|
tp53inp1
|
tumor protein p53 inducible nuclear protein 1 |
chr17_+_45395846 | 5.54 |
ENSDART00000058793
|
nenf
|
neudesin neurotrophic factor |
chr17_+_389218 | 5.53 |
ENSDART00000162898
|
si:rp71-62i8.1
|
si:rp71-62i8.1 |
chr17_+_50261603 | 5.53 |
ENSDART00000154503
ENSDART00000154467 |
syncripl
|
synaptotagmin binding, cytoplasmic RNA interacting protein, like |
chr6_-_40657653 | 5.52 |
ENSDART00000154359
|
ppil1
|
peptidylprolyl isomerase (cyclophilin)-like 1 |
chr6_+_18142623 | 5.52 |
ENSDART00000169431
ENSDART00000158841 |
si:dkey-237i9.8
|
si:dkey-237i9.8 |
chr10_+_8875195 | 5.52 |
ENSDART00000141045
|
itga2.3
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor), tandem duplicate 3 |
chr18_+_27598755 | 5.49 |
ENSDART00000193808
|
cd82b
|
CD82 molecule b |
chr22_-_17652914 | 5.45 |
ENSDART00000138483
|
si:ch73-243b8.4
|
si:ch73-243b8.4 |
chr8_-_21103522 | 5.41 |
ENSDART00000100283
|
aldh9a1a.1
|
aldehyde dehydrogenase 9 family, member A1a, tandem duplicate 1 |
chr21_+_233271 | 5.41 |
ENSDART00000171440
|
dtwd2
|
DTW domain containing 2 |
chr10_-_7671219 | 5.40 |
ENSDART00000159330
|
pcyox1
|
prenylcysteine oxidase 1 |
chr12_+_27232173 | 5.37 |
ENSDART00000193714
|
tmem106a
|
transmembrane protein 106A |
chr20_-_2619316 | 5.36 |
ENSDART00000185777
|
bub1
|
BUB1 mitotic checkpoint serine/threonine kinase |
chr5_-_2112030 | 5.35 |
ENSDART00000091932
|
gusb
|
glucuronidase, beta |
chr10_-_4980150 | 5.33 |
ENSDART00000093228
|
mat2al
|
methionine adenosyltransferase II, alpha-like |
chr24_-_1985007 | 5.31 |
ENSDART00000189870
|
PARD3 (1 of many)
|
par-3 family cell polarity regulator |
chr2_+_13069168 | 5.27 |
ENSDART00000192832
|
prkag2b
|
protein kinase, AMP-activated, gamma 2 non-catalytic subunit b |
chr20_+_13533544 | 5.26 |
ENSDART00000143115
|
sytl3
|
synaptotagmin-like 3 |
chr19_+_43523690 | 5.26 |
ENSDART00000113031
|
wasf2
|
WAS protein family, member 2 |
chr24_-_2423791 | 5.25 |
ENSDART00000190402
|
rreb1a
|
ras responsive element binding protein 1a |
chr3_-_27647845 | 5.23 |
ENSDART00000151625
|
si:ch211-157c3.4
|
si:ch211-157c3.4 |
chr1_+_58242498 | 5.23 |
ENSDART00000149091
|
ggt1l2.2
|
gamma-glutamyltransferase 1 like 2.2 |
chr8_-_41228530 | 5.23 |
ENSDART00000165949
ENSDART00000173055 |
fahd2a
|
fumarylacetoacetate hydrolase domain containing 2A |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.0 | 14.9 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) mitochondrial L-ornithine transmembrane transport(GO:1990575) |
4.9 | 14.6 | GO:0015889 | cobalt ion transport(GO:0006824) cobalamin transport(GO:0015889) |
3.9 | 11.7 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
3.6 | 10.9 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
3.5 | 10.4 | GO:0071236 | cellular response to antibiotic(GO:0071236) cellular response to toxic substance(GO:0097237) |
3.3 | 13.2 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
3.3 | 9.9 | GO:0097053 | L-kynurenine metabolic process(GO:0097052) L-kynurenine catabolic process(GO:0097053) |
2.9 | 8.8 | GO:1901052 | sarcosine metabolic process(GO:1901052) |
2.9 | 23.3 | GO:0032889 | regulation of vacuole fusion, non-autophagic(GO:0032889) |
2.5 | 17.7 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
2.5 | 10.0 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
2.5 | 7.4 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
2.2 | 8.9 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
2.0 | 8.2 | GO:0042117 | monocyte activation(GO:0042117) |
2.0 | 6.1 | GO:1990403 | embryonic brain development(GO:1990403) |
2.0 | 10.0 | GO:0019483 | beta-alanine metabolic process(GO:0019482) beta-alanine biosynthetic process(GO:0019483) |
2.0 | 13.9 | GO:0016139 | glycoside metabolic process(GO:0016137) glycoside catabolic process(GO:0016139) |
1.9 | 9.3 | GO:0072677 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
1.7 | 8.4 | GO:0033499 | galactose catabolic process(GO:0019388) galactose catabolic process via UDP-galactose(GO:0033499) |
1.5 | 9.2 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
1.5 | 7.3 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
1.4 | 4.1 | GO:0043903 | regulation of symbiosis, encompassing mutualism through parasitism(GO:0043903) |
1.3 | 5.2 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
1.3 | 3.8 | GO:0021698 | cerebellar Purkinje cell layer structural organization(GO:0021693) cerebellar cortex structural organization(GO:0021698) CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
1.3 | 3.8 | GO:1901890 | positive regulation of cell junction assembly(GO:1901890) |
1.2 | 7.1 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
1.2 | 11.8 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
1.2 | 4.6 | GO:0070166 | enamel mineralization(GO:0070166) |
1.1 | 10.3 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
1.1 | 4.5 | GO:0006843 | mitochondrial citrate transport(GO:0006843) |
1.1 | 4.5 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
1.1 | 6.6 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
1.1 | 3.3 | GO:1990511 | piRNA biosynthetic process(GO:1990511) |
1.1 | 5.4 | GO:0030327 | prenylated protein catabolic process(GO:0030327) prenylcysteine catabolic process(GO:0030328) prenylcysteine metabolic process(GO:0030329) |
1.1 | 5.4 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
1.1 | 3.2 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
1.1 | 3.2 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
1.1 | 7.4 | GO:0045123 | cellular extravasation(GO:0045123) |
1.0 | 24.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
1.0 | 3.1 | GO:0030043 | actin filament fragmentation(GO:0030043) |
1.0 | 5.1 | GO:0070650 | actin filament bundle distribution(GO:0070650) |
1.0 | 6.9 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
1.0 | 4.9 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
1.0 | 6.7 | GO:0032570 | response to progesterone(GO:0032570) |
0.9 | 10.4 | GO:0045453 | bone resorption(GO:0045453) |
0.9 | 4.7 | GO:0098751 | bone cell development(GO:0098751) |
0.9 | 6.6 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.9 | 11.1 | GO:0006559 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.9 | 3.7 | GO:0010039 | response to iron ion(GO:0010039) |
0.9 | 11.0 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.9 | 4.4 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.9 | 7.1 | GO:0042554 | superoxide anion generation(GO:0042554) |
0.9 | 5.3 | GO:0070254 | mucus secretion(GO:0070254) |
0.9 | 2.6 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.9 | 3.5 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.8 | 3.4 | GO:1903232 | melanosome assembly(GO:1903232) |
0.8 | 2.5 | GO:0002369 | T cell cytokine production(GO:0002369) |
0.8 | 4.2 | GO:0006660 | phosphatidylserine catabolic process(GO:0006660) monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
0.8 | 2.5 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.8 | 4.9 | GO:0060832 | oocyte animal/vegetal axis specification(GO:0060832) |
0.8 | 9.8 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.8 | 5.6 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.8 | 1.6 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.8 | 5.4 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.8 | 6.9 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.8 | 2.3 | GO:0044107 | calcitriol biosynthetic process from calciol(GO:0036378) vitamin D biosynthetic process(GO:0042368) cellular alcohol metabolic process(GO:0044107) cellular alcohol biosynthetic process(GO:0044108) |
0.8 | 0.8 | GO:0030237 | female sex determination(GO:0030237) |
0.8 | 2.3 | GO:0050787 | response to mercury ion(GO:0046689) detoxification of mercury ion(GO:0050787) |
0.7 | 3.0 | GO:0015859 | intracellular nucleoside transport(GO:0015859) purine nucleoside transmembrane transport(GO:0015860) purine nucleotide transport(GO:0015865) ATP transport(GO:0015867) purine ribonucleotide transport(GO:0015868) adenine nucleotide transport(GO:0051503) mitochondrial ATP transmembrane transport(GO:1990544) |
0.7 | 5.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.7 | 8.9 | GO:0050688 | regulation of defense response to virus(GO:0050688) |
0.7 | 8.2 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.7 | 5.9 | GO:0031179 | peptide modification(GO:0031179) |
0.7 | 13.2 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.7 | 2.9 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
0.7 | 7.7 | GO:2001235 | positive regulation of apoptotic signaling pathway(GO:2001235) |
0.7 | 7.0 | GO:0051601 | exocyst localization(GO:0051601) |
0.7 | 2.8 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.7 | 2.1 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.7 | 1.4 | GO:0060193 | positive regulation of phospholipase activity(GO:0010518) positive regulation of lipase activity(GO:0060193) |
0.7 | 5.5 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.7 | 26.8 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.7 | 2.7 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.7 | 2.7 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.7 | 28.2 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.6 | 9.7 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.6 | 1.9 | GO:0002639 | regulation of immunoglobulin production(GO:0002637) positive regulation of immunoglobulin production(GO:0002639) |
0.6 | 1.9 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.6 | 4.5 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.6 | 7.0 | GO:0006798 | polyphosphate metabolic process(GO:0006797) polyphosphate catabolic process(GO:0006798) |
0.6 | 9.3 | GO:2000601 | positive regulation of actin nucleation(GO:0051127) positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.6 | 1.8 | GO:0060148 | negative regulation of hippo signaling(GO:0035331) positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
0.6 | 3.6 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.6 | 10.3 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.6 | 9.0 | GO:2000223 | regulation of BMP signaling pathway involved in heart jogging(GO:2000223) |
0.6 | 30.1 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.6 | 1.8 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) protein localization to nuclear envelope(GO:0090435) |
0.6 | 1.2 | GO:0098586 | cytoplasmic pattern recognition receptor signaling pathway in response to virus(GO:0039528) cellular response to virus(GO:0098586) |
0.6 | 8.1 | GO:0046051 | UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
0.6 | 1.7 | GO:0005985 | sucrose metabolic process(GO:0005985) sucrose biosynthetic process(GO:0005986) disaccharide biosynthetic process(GO:0046351) |
0.6 | 1.7 | GO:0000390 | spliceosomal complex disassembly(GO:0000390) |
0.6 | 5.2 | GO:1901998 | toxin transport(GO:1901998) |
0.6 | 1.7 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.6 | 1.7 | GO:0010359 | regulation of anion channel activity(GO:0010359) |
0.6 | 2.3 | GO:0009447 | polyamine catabolic process(GO:0006598) putrescine catabolic process(GO:0009447) |
0.6 | 2.8 | GO:0003210 | cardiac atrium formation(GO:0003210) |
0.6 | 3.3 | GO:0060149 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by miRNA(GO:0060965) negative regulation of gene silencing by RNA(GO:0060967) |
0.6 | 3.9 | GO:0030194 | positive regulation of blood coagulation(GO:0030194) positive regulation of coagulation(GO:0050820) positive regulation of hemostasis(GO:1900048) |
0.6 | 2.2 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.6 | 8.3 | GO:0003313 | heart rudiment development(GO:0003313) |
0.6 | 3.3 | GO:0046146 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.5 | 35.2 | GO:0030834 | regulation of actin filament depolymerization(GO:0030834) negative regulation of actin filament depolymerization(GO:0030835) |
0.5 | 1.6 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.5 | 0.5 | GO:0071634 | regulation of transforming growth factor beta production(GO:0071634) negative regulation of transforming growth factor beta production(GO:0071635) |
0.5 | 5.9 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous antigen(GO:0019883) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.5 | 1.6 | GO:0015695 | organic cation transport(GO:0015695) |
0.5 | 14.5 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.5 | 0.5 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.5 | 3.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.5 | 1.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.5 | 1.0 | GO:0010828 | positive regulation of glucose transport(GO:0010828) |
0.5 | 3.6 | GO:0009136 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
0.5 | 1.6 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.5 | 3.5 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
0.5 | 1.0 | GO:0060043 | regulation of cardiac muscle tissue growth(GO:0055021) regulation of cardiac muscle cell proliferation(GO:0060043) |
0.5 | 5.0 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.5 | 5.5 | GO:0006032 | chitin catabolic process(GO:0006032) |
0.5 | 1.5 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.5 | 10.9 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.5 | 7.4 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.5 | 1.9 | GO:0034087 | establishment of mitotic sister chromatid cohesion(GO:0034087) |
0.5 | 1.9 | GO:0033301 | cell cycle comprising mitosis without cytokinesis(GO:0033301) |
0.5 | 35.7 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.5 | 23.0 | GO:0070830 | apical junction assembly(GO:0043297) bicellular tight junction assembly(GO:0070830) |
0.5 | 2.3 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.5 | 2.8 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
0.5 | 7.9 | GO:0033077 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
0.5 | 7.3 | GO:0019985 | translesion synthesis(GO:0019985) |
0.5 | 0.9 | GO:0030238 | male sex determination(GO:0030238) |
0.5 | 3.6 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.5 | 2.3 | GO:0050927 | regulation of positive chemotaxis(GO:0050926) positive regulation of positive chemotaxis(GO:0050927) induction of positive chemotaxis(GO:0050930) |
0.5 | 1.8 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.4 | 6.7 | GO:0061055 | myotome development(GO:0061055) |
0.4 | 17.8 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.4 | 2.2 | GO:0043535 | regulation of blood vessel endothelial cell migration(GO:0043535) |
0.4 | 0.9 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.4 | 3.1 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.4 | 5.7 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) response to growth hormone(GO:0060416) cellular response to growth hormone stimulus(GO:0071378) |
0.4 | 2.6 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.4 | 2.2 | GO:0051148 | negative regulation of muscle cell differentiation(GO:0051148) |
0.4 | 1.3 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.4 | 1.7 | GO:0048913 | anterior lateral line nerve glial cell differentiation(GO:0048913) myelination of anterior lateral line nerve axons(GO:0048914) anterior lateral line nerve glial cell development(GO:0048939) anterior lateral line nerve glial cell morphogenesis involved in differentiation(GO:0048940) |
0.4 | 8.4 | GO:0035723 | interleukin-15-mediated signaling pathway(GO:0035723) response to interleukin-15(GO:0070672) cellular response to interleukin-15(GO:0071350) |
0.4 | 5.1 | GO:0043651 | lipoxygenase pathway(GO:0019372) linoleic acid metabolic process(GO:0043651) hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.4 | 8.0 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.4 | 1.3 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.4 | 1.3 | GO:1902767 | farnesyl diphosphate biosynthetic process, mevalonate pathway(GO:0010142) isoprenoid biosynthetic process via mevalonate(GO:1902767) |
0.4 | 8.3 | GO:0002574 | thrombocyte differentiation(GO:0002574) |
0.4 | 7.9 | GO:0008354 | germ cell migration(GO:0008354) |
0.4 | 5.4 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) positive regulation of cAMP metabolic process(GO:0030816) positive regulation of cAMP biosynthetic process(GO:0030819) positive regulation of adenylate cyclase activity(GO:0045762) |
0.4 | 3.6 | GO:1990402 | embryonic liver development(GO:1990402) |
0.4 | 5.6 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.4 | 2.4 | GO:0010269 | response to selenium ion(GO:0010269) |
0.4 | 4.0 | GO:0098869 | response to superoxide(GO:0000303) response to oxygen radical(GO:0000305) removal of superoxide radicals(GO:0019430) cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) cellular oxidant detoxification(GO:0098869) cellular detoxification(GO:1990748) |
0.4 | 3.6 | GO:0055129 | proline biosynthetic process(GO:0006561) L-proline biosynthetic process(GO:0055129) |
0.4 | 2.7 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.4 | 0.8 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.4 | 14.0 | GO:0003094 | glomerular filtration(GO:0003094) |
0.4 | 1.5 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
0.4 | 6.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.4 | 2.3 | GO:0045658 | regulation of granulocyte differentiation(GO:0030852) regulation of neutrophil differentiation(GO:0045658) |
0.4 | 1.5 | GO:0032534 | regulation of microvillus organization(GO:0032530) regulation of microvillus assembly(GO:0032534) |
0.4 | 3.4 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.4 | 4.6 | GO:2000403 | positive regulation of lymphocyte migration(GO:2000403) positive regulation of T cell migration(GO:2000406) |
0.4 | 3.8 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.4 | 2.6 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.4 | 1.5 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.4 | 1.9 | GO:0034063 | stress granule assembly(GO:0034063) |
0.4 | 7.1 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.4 | 13.0 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.4 | 5.4 | GO:0043248 | proteasome assembly(GO:0043248) |
0.4 | 2.1 | GO:0006574 | valine catabolic process(GO:0006574) |
0.4 | 3.2 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.4 | 7.8 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.4 | 1.8 | GO:0035678 | neuromast hair cell morphogenesis(GO:0035678) |
0.4 | 0.4 | GO:2000471 | regulation of hematopoietic stem cell migration(GO:2000471) |
0.4 | 1.4 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.3 | 1.7 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.3 | 0.3 | GO:0045923 | positive regulation of fatty acid metabolic process(GO:0045923) |
0.3 | 1.7 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.3 | 2.4 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.3 | 1.0 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.3 | 1.4 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.3 | 6.1 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
0.3 | 2.0 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.3 | 1.0 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.3 | 1.3 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.3 | 7.7 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.3 | 1.3 | GO:0033340 | pelvic fin development(GO:0033340) |
0.3 | 1.7 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
0.3 | 1.0 | GO:0048211 | Golgi vesicle docking(GO:0048211) |
0.3 | 3.6 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.3 | 2.3 | GO:1902315 | cell cycle DNA replication initiation(GO:1902292) nuclear cell cycle DNA replication initiation(GO:1902315) mitotic DNA replication initiation(GO:1902975) |
0.3 | 3.5 | GO:0046427 | positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
0.3 | 9.6 | GO:0001569 | patterning of blood vessels(GO:0001569) |
0.3 | 2.6 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.3 | 2.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.3 | 1.6 | GO:0055024 | regulation of cardiac muscle tissue development(GO:0055024) regulation of cardiocyte differentiation(GO:1905207) regulation of cardiac muscle cell differentiation(GO:2000725) |
0.3 | 0.6 | GO:0003091 | renal water homeostasis(GO:0003091) renal water transport(GO:0003097) multicellular organismal water homeostasis(GO:0050891) |
0.3 | 1.3 | GO:0097535 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
0.3 | 0.9 | GO:0097095 | frontonasal suture morphogenesis(GO:0097095) |
0.3 | 9.8 | GO:0032355 | response to estradiol(GO:0032355) |
0.3 | 1.9 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.3 | 8.7 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.3 | 4.0 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.3 | 21.1 | GO:0006612 | protein targeting to membrane(GO:0006612) |
0.3 | 0.9 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.3 | 1.2 | GO:0001715 | ectodermal cell fate commitment(GO:0001712) ectodermal cell fate specification(GO:0001715) ectodermal cell differentiation(GO:0010668) regulation of ectodermal cell fate specification(GO:0042665) regulation of ectoderm development(GO:2000383) |
0.3 | 2.7 | GO:0045444 | fat cell differentiation(GO:0045444) |
0.3 | 2.1 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.3 | 6.8 | GO:1902622 | regulation of neutrophil migration(GO:1902622) |
0.3 | 4.1 | GO:0032264 | IMP salvage(GO:0032264) |
0.3 | 0.9 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.3 | 3.5 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.3 | 1.2 | GO:0021755 | eurydendroid cell differentiation(GO:0021755) |
0.3 | 2.9 | GO:0002688 | regulation of leukocyte chemotaxis(GO:0002688) |
0.3 | 0.9 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.3 | 1.4 | GO:0010332 | response to gamma radiation(GO:0010332) cellular response to gamma radiation(GO:0071480) |
0.3 | 1.7 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.3 | 0.6 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.3 | 1.7 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.3 | 6.2 | GO:0009408 | response to heat(GO:0009408) |
0.3 | 1.4 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.3 | 2.8 | GO:0015810 | acidic amino acid transport(GO:0015800) aspartate transport(GO:0015810) L-glutamate transport(GO:0015813) malate-aspartate shuttle(GO:0043490) |
0.3 | 5.6 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.3 | 13.4 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.3 | 27.6 | GO:0009410 | response to xenobiotic stimulus(GO:0009410) |
0.3 | 1.1 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.3 | 1.9 | GO:0071156 | regulation of cell cycle arrest(GO:0071156) |
0.3 | 4.1 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.3 | 7.6 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.3 | 6.2 | GO:0051639 | actin filament network formation(GO:0051639) |
0.3 | 3.5 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.3 | 0.8 | GO:1905168 | positive regulation of double-strand break repair via homologous recombination(GO:1905168) |
0.3 | 1.9 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.3 | 1.3 | GO:0070986 | left/right axis specification(GO:0070986) |
0.3 | 1.3 | GO:0014028 | notochord formation(GO:0014028) |
0.3 | 0.8 | GO:0090004 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.3 | 9.2 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.3 | 7.1 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.3 | 2.6 | GO:0002761 | regulation of myeloid leukocyte differentiation(GO:0002761) |
0.3 | 1.0 | GO:0048903 | anterior lateral line neuromast hair cell differentiation(GO:0048903) |
0.3 | 2.3 | GO:2000273 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) positive regulation of receptor activity(GO:2000273) |
0.3 | 0.8 | GO:0014005 | microglia development(GO:0014005) |
0.3 | 1.5 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.3 | 1.5 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.3 | 0.5 | GO:0030002 | cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.3 | 2.5 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.3 | 10.5 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.2 | 3.7 | GO:1990266 | neutrophil migration(GO:1990266) |
0.2 | 2.2 | GO:2001239 | histone dephosphorylation(GO:0016576) negative regulation of signal transduction in absence of ligand(GO:1901099) regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.2 | 1.0 | GO:0003173 | ventriculo bulbo valve development(GO:0003173) |
0.2 | 0.7 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.2 | 6.8 | GO:0001878 | response to yeast(GO:0001878) |
0.2 | 3.6 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.2 | 7.0 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.2 | 0.7 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.2 | 25.4 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.2 | 0.9 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.2 | 0.9 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) cardiac chamber ballooning(GO:0003242) cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
0.2 | 3.0 | GO:0050727 | regulation of inflammatory response(GO:0050727) |
0.2 | 0.7 | GO:0035971 | peptidyl-histidine dephosphorylation(GO:0035971) |
0.2 | 1.1 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.2 | 3.9 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.2 | 1.6 | GO:0031048 | chromatin silencing by small RNA(GO:0031048) |
0.2 | 0.5 | GO:0044246 | regulation of collagen metabolic process(GO:0010712) regulation of collagen biosynthetic process(GO:0032965) regulation of multicellular organismal metabolic process(GO:0044246) |
0.2 | 3.4 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.2 | 3.4 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.2 | 1.8 | GO:0001818 | negative regulation of cytokine production(GO:0001818) |
0.2 | 3.3 | GO:0000302 | response to reactive oxygen species(GO:0000302) |
0.2 | 11.7 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.2 | 2.4 | GO:0042026 | protein refolding(GO:0042026) |
0.2 | 7.5 | GO:0046466 | sphingolipid catabolic process(GO:0030149) membrane lipid catabolic process(GO:0046466) |
0.2 | 2.6 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.2 | 0.9 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 2.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.2 | 1.7 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.2 | 0.9 | GO:0099563 | modification of synaptic structure(GO:0099563) |
0.2 | 2.8 | GO:1901888 | regulation of cell junction assembly(GO:1901888) |
0.2 | 49.1 | GO:0009617 | response to bacterium(GO:0009617) |
0.2 | 4.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.2 | 20.9 | GO:0019221 | cytokine-mediated signaling pathway(GO:0019221) |
0.2 | 1.1 | GO:0097355 | protein localization to heterochromatin(GO:0097355) |
0.2 | 0.8 | GO:0032608 | interferon-beta production(GO:0032608) regulation of interferon-beta production(GO:0032648) positive regulation of interferon-beta production(GO:0032728) |
0.2 | 2.9 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.2 | 1.3 | GO:0016441 | posttranscriptional gene silencing(GO:0016441) posttranscriptional gene silencing by RNA(GO:0035194) |
0.2 | 0.6 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.2 | 4.1 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.2 | 0.6 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.2 | 1.0 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.2 | 8.7 | GO:0051607 | defense response to virus(GO:0051607) |
0.2 | 3.2 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.2 | 3.8 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.2 | 13.9 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.2 | 2.8 | GO:0036065 | fucosylation(GO:0036065) |
0.2 | 2.2 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.2 | 4.1 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.2 | 1.2 | GO:0071800 | podosome assembly(GO:0071800) |
0.2 | 1.0 | GO:0050848 | regulation of calcium-mediated signaling(GO:0050848) |
0.2 | 2.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 1.1 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
0.2 | 0.4 | GO:0044854 | membrane raft assembly(GO:0001765) plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
0.2 | 2.2 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.2 | 0.9 | GO:0007584 | response to nutrient(GO:0007584) |
0.2 | 1.1 | GO:0072091 | regulation of stem cell proliferation(GO:0072091) |
0.2 | 0.9 | GO:0007143 | female meiotic division(GO:0007143) |
0.2 | 3.0 | GO:0046461 | triglyceride catabolic process(GO:0019433) neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.2 | 0.5 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.2 | 0.5 | GO:0035992 | tendon formation(GO:0035992) |
0.2 | 1.7 | GO:0034672 | anterior/posterior pattern specification involved in pronephros development(GO:0034672) anterior/posterior pattern specification involved in kidney development(GO:0072098) |
0.2 | 4.2 | GO:0072376 | complement activation(GO:0006956) protein activation cascade(GO:0072376) |
0.2 | 2.9 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.2 | 1.7 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.2 | 0.7 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) regulation of cellular amine metabolic process(GO:0033238) |
0.2 | 0.5 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.2 | 2.5 | GO:0031167 | rRNA methylation(GO:0031167) |
0.2 | 1.2 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.2 | 3.8 | GO:0032292 | peripheral nervous system axon ensheathment(GO:0032292) |
0.2 | 6.4 | GO:0007599 | blood coagulation(GO:0007596) hemostasis(GO:0007599) |
0.2 | 1.3 | GO:0042694 | muscle cell fate specification(GO:0042694) |
0.2 | 1.0 | GO:0001881 | receptor recycling(GO:0001881) |
0.2 | 1.3 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.2 | 4.6 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
0.2 | 0.2 | GO:0010827 | regulation of glucose transport(GO:0010827) regulation of glucose import(GO:0046324) |
0.2 | 5.6 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.2 | 1.1 | GO:0019359 | NAD biosynthetic process(GO:0009435) nicotinamide nucleotide biosynthetic process(GO:0019359) pyridine nucleotide biosynthetic process(GO:0019363) |
0.2 | 1.7 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.2 | 2.8 | GO:0001966 | thigmotaxis(GO:0001966) |
0.2 | 1.4 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.2 | 0.8 | GO:0060561 | apoptotic process involved in morphogenesis(GO:0060561) |
0.2 | 11.6 | GO:0071559 | transforming growth factor beta receptor signaling pathway(GO:0007179) response to transforming growth factor beta(GO:0071559) cellular response to transforming growth factor beta stimulus(GO:0071560) |
0.2 | 2.4 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.2 | 0.8 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
0.2 | 0.3 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.2 | 4.6 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.2 | 3.5 | GO:0032925 | regulation of activin receptor signaling pathway(GO:0032925) |
0.1 | 1.0 | GO:0046320 | regulation of fatty acid beta-oxidation(GO:0031998) regulation of fatty acid oxidation(GO:0046320) |
0.1 | 3.3 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.6 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 1.2 | GO:0006477 | protein sulfation(GO:0006477) peptidyl-tyrosine sulfation(GO:0006478) |
0.1 | 7.4 | GO:0045214 | sarcomere organization(GO:0045214) |
0.1 | 3.8 | GO:0051180 | vitamin transport(GO:0051180) |
0.1 | 2.2 | GO:0002250 | adaptive immune response(GO:0002250) |
0.1 | 3.5 | GO:0010821 | regulation of mitochondrion organization(GO:0010821) |
0.1 | 2.3 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 1.1 | GO:0051125 | regulation of actin nucleation(GO:0051125) |
0.1 | 1.2 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.8 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.1 | 6.2 | GO:0030050 | vesicle transport along actin filament(GO:0030050) actin filament-based transport(GO:0099515) |
0.1 | 3.9 | GO:0032526 | response to retinoic acid(GO:0032526) |
0.1 | 0.8 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.1 | 0.5 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.1 | 2.0 | GO:0001556 | oocyte maturation(GO:0001556) |
0.1 | 2.3 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.8 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 3.5 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.1 | 1.9 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.1 | 4.1 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.1 | 9.9 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 1.1 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.1 | 0.6 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.1 | 3.1 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 2.4 | GO:0044773 | mitotic DNA damage checkpoint(GO:0044773) |
0.1 | 0.8 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 0.9 | GO:0046958 | nonassociative learning(GO:0046958) habituation(GO:0046959) |
0.1 | 1.5 | GO:0006599 | phosphagen metabolic process(GO:0006599) phosphocreatine metabolic process(GO:0006603) phosphagen biosynthetic process(GO:0042396) phosphocreatine biosynthetic process(GO:0046314) |
0.1 | 1.9 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 2.5 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.1 | 4.0 | GO:0032963 | collagen metabolic process(GO:0032963) multicellular organismal macromolecule metabolic process(GO:0044259) |
0.1 | 3.0 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.1 | 1.2 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.1 | 1.5 | GO:1903670 | regulation of sprouting angiogenesis(GO:1903670) |
0.1 | 5.1 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade(GO:0070374) |
0.1 | 0.7 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.1 | 1.2 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.1 | 0.4 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.1 | 10.9 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
0.1 | 0.8 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 2.7 | GO:0045010 | actin nucleation(GO:0045010) |
0.1 | 2.2 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 1.9 | GO:0014065 | phosphatidylinositol 3-kinase signaling(GO:0014065) |
0.1 | 0.4 | GO:0010610 | regulation of mRNA stability involved in response to stress(GO:0010610) regulation of mRNA stability involved in response to oxidative stress(GO:2000815) |
0.1 | 1.1 | GO:0018120 | peptidyl-arginine ADP-ribosylation(GO:0018120) |
0.1 | 28.6 | GO:0006955 | immune response(GO:0006955) |
0.1 | 8.2 | GO:0016072 | rRNA metabolic process(GO:0016072) |
0.1 | 0.3 | GO:1904103 | regulation of convergent extension involved in gastrulation(GO:1904103) |
0.1 | 0.8 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.8 | GO:0060217 | hemangioblast cell differentiation(GO:0060217) |
0.1 | 0.9 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 1.1 | GO:0021592 | fourth ventricle development(GO:0021592) |
0.1 | 2.4 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 1.3 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 1.3 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) |
0.1 | 0.3 | GO:1903173 | fatty alcohol metabolic process(GO:1903173) |
0.1 | 4.4 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 1.2 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.1 | 5.1 | GO:0060048 | cardiac muscle contraction(GO:0060048) |
0.1 | 1.7 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
0.1 | 0.7 | GO:0043114 | regulation of vascular permeability(GO:0043114) |
0.1 | 1.3 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
0.1 | 1.5 | GO:0060324 | face development(GO:0060324) |
0.1 | 0.7 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.1 | 0.7 | GO:0035196 | production of miRNAs involved in gene silencing by miRNA(GO:0035196) |
0.1 | 1.7 | GO:0045727 | positive regulation of cellular amide metabolic process(GO:0034250) positive regulation of translation(GO:0045727) |
0.1 | 0.8 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.1 | 0.5 | GO:0006582 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
0.1 | 0.2 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.1 | 0.7 | GO:0008105 | asymmetric protein localization(GO:0008105) apical protein localization(GO:0045176) |
0.1 | 0.7 | GO:0009636 | response to toxic substance(GO:0009636) |
0.1 | 1.0 | GO:0009409 | response to cold(GO:0009409) |
0.1 | 3.1 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 0.6 | GO:0039023 | pronephric duct morphogenesis(GO:0039023) |
0.1 | 2.4 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
0.1 | 0.9 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.1 | 0.4 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.1 | 0.9 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.1 | 1.9 | GO:0051209 | release of sequestered calcium ion into cytosol(GO:0051209) |
0.1 | 3.5 | GO:0044744 | protein import into nucleus(GO:0006606) protein targeting to nucleus(GO:0044744) single-organism nuclear import(GO:1902593) |
0.1 | 0.2 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 1.1 | GO:0035803 | binding of sperm to zona pellucida(GO:0007339) egg coat formation(GO:0035803) regulation of acrosome reaction(GO:0060046) positive regulation of acrosome reaction(GO:2000344) |
0.1 | 0.8 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.1 | 0.5 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 2.0 | GO:0006913 | nucleocytoplasmic transport(GO:0006913) nuclear transport(GO:0051169) |
0.1 | 1.5 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
0.1 | 0.2 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) N-terminal peptidyl-glycine N-myristoylation(GO:0018008) protein myristoylation(GO:0018377) |
0.1 | 1.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.2 | GO:0098921 | endocannabinoid signaling pathway(GO:0071926) retrograde trans-synaptic signaling(GO:0098917) retrograde trans-synaptic signaling by lipid(GO:0098920) retrograde trans-synaptic signaling by endocannabinoid(GO:0098921) |
0.1 | 0.3 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.1 | 0.6 | GO:0070142 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) synaptic vesicle budding(GO:0070142) |
0.1 | 0.8 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) |
0.1 | 0.4 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.1 | 0.6 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.1 | 0.9 | GO:0021551 | central nervous system morphogenesis(GO:0021551) |
0.0 | 0.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.0 | 1.5 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.0 | 2.9 | GO:0006006 | glucose metabolic process(GO:0006006) |
0.0 | 1.5 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.0 | 14.7 | GO:0006412 | translation(GO:0006412) |
0.0 | 0.5 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.0 | 0.9 | GO:0045103 | intermediate filament-based process(GO:0045103) intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.6 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.5 | GO:0036368 | cone photoresponse recovery(GO:0036368) |
0.0 | 0.1 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.0 | 1.1 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.0 | 0.6 | GO:0007634 | optokinetic behavior(GO:0007634) |
0.0 | 1.3 | GO:0031623 | receptor internalization(GO:0031623) |
0.0 | 0.2 | GO:0060232 | delamination(GO:0060232) |
0.0 | 0.1 | GO:0019370 | leukotriene metabolic process(GO:0006691) leukotriene biosynthetic process(GO:0019370) |
0.0 | 1.6 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.0 | 0.2 | GO:2001057 | reactive nitrogen species metabolic process(GO:2001057) |
0.0 | 0.7 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.0 | 0.1 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.3 | GO:0036372 | opsin transport(GO:0036372) |
0.0 | 2.5 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.3 | GO:0035188 | hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.3 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.0 | 0.3 | GO:0045740 | positive regulation of DNA replication(GO:0045740) |
0.0 | 1.4 | GO:0008285 | negative regulation of cell proliferation(GO:0008285) |
0.0 | 1.2 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.0 | 0.2 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.3 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.0 | 0.6 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.0 | 0.6 | GO:0061351 | neural precursor cell proliferation(GO:0061351) |
0.0 | 1.1 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.0 | 3.6 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 1.5 | GO:0035567 | non-canonical Wnt signaling pathway(GO:0035567) |
0.0 | 0.4 | GO:0003171 | atrioventricular valve development(GO:0003171) |
0.0 | 0.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 0.2 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.0 | 0.4 | GO:0003014 | renal system process(GO:0003014) |
0.0 | 0.6 | GO:0006182 | cGMP biosynthetic process(GO:0006182) cGMP metabolic process(GO:0046068) |
0.0 | 0.5 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.0 | 0.6 | GO:0030837 | negative regulation of actin filament polymerization(GO:0030837) negative regulation of protein polymerization(GO:0032272) |
0.0 | 0.5 | GO:0046460 | triglyceride biosynthetic process(GO:0019432) neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
0.0 | 0.2 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.3 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 1.2 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.5 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
0.0 | 0.3 | GO:0019827 | stem cell population maintenance(GO:0019827) |
0.0 | 0.2 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.0 | 0.2 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 1.8 | GO:0001503 | ossification(GO:0001503) |
0.0 | 0.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.0 | 0.2 | GO:0006298 | mismatch repair(GO:0006298) |
0.0 | 1.0 | GO:0070121 | Kupffer's vesicle development(GO:0070121) |
0.0 | 0.3 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 0.2 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.0 | 0.8 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.0 | 0.3 | GO:0098962 | regulation of postsynaptic neurotransmitter receptor activity(GO:0098962) |
0.0 | 0.4 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.0 | 0.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.1 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
0.0 | 0.5 | GO:0031103 | axon regeneration(GO:0031103) response to axon injury(GO:0048678) |
0.0 | 0.1 | GO:1901642 | nucleoside transport(GO:0015858) nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.1 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.3 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.0 | 0.1 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 26.6 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
2.9 | 23.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
2.4 | 9.5 | GO:0005588 | collagen type V trimer(GO:0005588) |
2.3 | 11.7 | GO:0097433 | dense body(GO:0097433) |
2.1 | 6.3 | GO:0042709 | succinate-CoA ligase complex(GO:0042709) |
1.7 | 5.2 | GO:0032998 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
1.6 | 6.6 | GO:0019815 | B cell receptor complex(GO:0019815) |
1.6 | 4.7 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.5 | 71.2 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
1.4 | 5.7 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
1.4 | 5.6 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
1.4 | 5.5 | GO:0097524 | sperm plasma membrane(GO:0097524) |
1.2 | 76.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
1.2 | 9.3 | GO:0001772 | immunological synapse(GO:0001772) |
1.0 | 6.0 | GO:0030891 | VCB complex(GO:0030891) |
1.0 | 3.9 | GO:0098890 | extrinsic component of postsynaptic membrane(GO:0098890) |
1.0 | 2.9 | GO:0031310 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
1.0 | 3.8 | GO:0016600 | flotillin complex(GO:0016600) |
0.9 | 2.8 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.9 | 12.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.9 | 3.5 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.9 | 2.6 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
0.8 | 3.4 | GO:0031085 | BLOC-3 complex(GO:0031085) |
0.8 | 2.5 | GO:0005775 | vacuolar lumen(GO:0005775) lysosomal lumen(GO:0043202) |
0.8 | 5.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.8 | 3.2 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.8 | 3.2 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
0.8 | 3.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.8 | 6.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.8 | 8.6 | GO:0045095 | keratin filament(GO:0045095) |
0.8 | 4.6 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.8 | 1.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.8 | 2.3 | GO:0098536 | deuterosome(GO:0098536) |
0.7 | 3.6 | GO:1990071 | TRAPPII protein complex(GO:1990071) |
0.7 | 7.2 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.7 | 2.1 | GO:0034709 | methylosome(GO:0034709) |
0.7 | 3.3 | GO:1990923 | PET complex(GO:1990923) |
0.6 | 4.3 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.6 | 4.3 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.6 | 4.9 | GO:0032019 | mitochondrial cloud(GO:0032019) |
0.6 | 6.6 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.6 | 4.1 | GO:1990130 | Iml1 complex(GO:1990130) |
0.6 | 11.1 | GO:0005903 | brush border(GO:0005903) |
0.6 | 2.3 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.6 | 8.1 | GO:0002102 | podosome(GO:0002102) |
0.6 | 5.2 | GO:0070938 | contractile ring(GO:0070938) |
0.6 | 5.5 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.6 | 7.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.5 | 10.6 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.5 | 2.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.5 | 2.0 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
0.5 | 13.5 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.5 | 14.5 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.5 | 1.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.5 | 23.8 | GO:0005902 | microvillus(GO:0005902) |
0.5 | 5.6 | GO:0044295 | axonal growth cone(GO:0044295) |
0.5 | 1.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.4 | 2.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.4 | 2.1 | GO:0018444 | translation release factor complex(GO:0018444) |
0.4 | 1.7 | GO:1904423 | dehydrodolichyl diphosphate synthase complex(GO:1904423) |
0.4 | 2.0 | GO:0031415 | NatA complex(GO:0031415) |
0.4 | 1.6 | GO:0005579 | membrane attack complex(GO:0005579) |
0.4 | 2.8 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.4 | 7.2 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.4 | 2.4 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.4 | 11.0 | GO:0035861 | site of double-strand break(GO:0035861) |
0.4 | 7.0 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) condensed nuclear chromosome, centromeric region(GO:0000780) |
0.4 | 0.8 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.4 | 2.3 | GO:0000938 | GARP complex(GO:0000938) |
0.4 | 6.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.4 | 1.9 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.4 | 2.2 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.4 | 1.8 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.3 | 3.8 | GO:0000177 | nuclear exosome (RNase complex)(GO:0000176) cytoplasmic exosome (RNase complex)(GO:0000177) |
0.3 | 2.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.3 | 8.5 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.3 | 4.3 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
0.3 | 2.6 | GO:0000796 | condensin complex(GO:0000796) |
0.3 | 6.1 | GO:0098844 | postsynaptic endocytic zone membrane(GO:0098844) |
0.3 | 6.7 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.3 | 1.6 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.3 | 2.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.3 | 1.2 | GO:0016460 | myosin II complex(GO:0016460) |
0.3 | 4.8 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.3 | 81.2 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.3 | 6.8 | GO:0032040 | small-subunit processome(GO:0032040) |
0.3 | 2.9 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.3 | 2.6 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.3 | 2.5 | GO:0019908 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.3 | 33.5 | GO:0070160 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.3 | 1.9 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.3 | 0.8 | GO:1990879 | CST complex(GO:1990879) |
0.3 | 1.0 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.3 | 1.5 | GO:0005784 | Sec61 translocon complex(GO:0005784) |
0.2 | 1.5 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.2 | 7.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 26.3 | GO:0005884 | actin filament(GO:0005884) |
0.2 | 12.0 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 21.0 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.2 | 0.9 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 11.6 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 5.2 | GO:0005795 | Golgi stack(GO:0005795) |
0.2 | 15.0 | GO:0030027 | lamellipodium(GO:0030027) |
0.2 | 2.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 3.8 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.2 | 1.2 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
0.2 | 11.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 0.6 | GO:0097361 | CIA complex(GO:0097361) |
0.2 | 1.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 0.7 | GO:0017177 | glucosidase II complex(GO:0017177) |
0.2 | 2.0 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.2 | 0.5 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) catalytic step 1 spliceosome(GO:0071012) |
0.2 | 11.5 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.2 | 0.7 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
0.2 | 15.7 | GO:0016459 | myosin complex(GO:0016459) |
0.2 | 3.6 | GO:0005686 | U2 snRNP(GO:0005686) |
0.2 | 1.5 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 0.7 | GO:0061702 | inflammasome complex(GO:0061702) |
0.2 | 0.8 | GO:0000811 | GINS complex(GO:0000811) |
0.2 | 2.7 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 1.9 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.2 | 0.8 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.2 | 1.4 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.2 | 1.2 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.2 | 4.1 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.1 | 0.9 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 19.7 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 10.4 | GO:0031228 | integral component of Golgi membrane(GO:0030173) intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 8.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 2.6 | GO:0033290 | eukaryotic 48S preinitiation complex(GO:0033290) |
0.1 | 2.1 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.1 | 1.0 | GO:0034991 | nuclear cohesin complex(GO:0000798) mitotic cohesin complex(GO:0030892) nuclear mitotic cohesin complex(GO:0034990) nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 1.0 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 1.9 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 169.3 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 7.7 | GO:0005865 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
0.1 | 1.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 8.9 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 0.4 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 1.6 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 86.1 | GO:0005576 | extracellular region(GO:0005576) |
0.1 | 1.5 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 1.9 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 3.0 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.1 | 6.7 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 6.3 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 10.0 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 2.1 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 1.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 5.4 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.4 | GO:0035301 | Hedgehog signaling complex(GO:0035301) |
0.1 | 4.5 | GO:0008305 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.1 | 0.4 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.1 | 2.6 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 0.6 | GO:0035101 | FACT complex(GO:0035101) |
0.1 | 1.2 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 0.3 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 1.2 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 1.5 | GO:0008278 | cohesin complex(GO:0008278) |
0.1 | 0.7 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 6.4 | GO:0005764 | lysosome(GO:0005764) |
0.1 | 1.7 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 8.7 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 1.2 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 2.9 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 1.9 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.4 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 0.5 | GO:0016586 | RSC complex(GO:0016586) |
0.1 | 1.0 | GO:0000784 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) nuclear chromosome, telomeric region(GO:0000784) |
0.1 | 1.3 | GO:0043186 | P granule(GO:0043186) |
0.1 | 0.6 | GO:0098835 | presynaptic endocytic zone(GO:0098833) presynaptic endocytic zone membrane(GO:0098835) extrinsic component of presynaptic membrane(GO:0098888) extrinsic component of presynaptic endocytic zone(GO:0098894) |
0.1 | 0.7 | GO:0005685 | U1 snRNP(GO:0005685) |
0.0 | 0.5 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.0 | 1.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 2.4 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.6 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 1.3 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 1.8 | GO:0016605 | PML body(GO:0016605) |
0.0 | 1.1 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.0 | 0.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.4 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 3.3 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.6 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.7 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 2.6 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.7 | GO:1990391 | DNA repair complex(GO:1990391) |
0.0 | 0.3 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.0 | 0.6 | GO:0097517 | stress fiber(GO:0001725) actomyosin(GO:0042641) contractile actin filament bundle(GO:0097517) |
0.0 | 0.2 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 0.4 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.1 | GO:0097550 | transcription factor TFIIIB complex(GO:0000126) transcriptional preinitiation complex(GO:0097550) |
0.0 | 0.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.7 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 1.3 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 2.6 | GO:0005730 | nucleolus(GO:0005730) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 23.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
2.9 | 8.6 | GO:0004557 | alpha-galactosidase activity(GO:0004557) |
2.7 | 10.9 | GO:0003796 | lysozyme activity(GO:0003796) |
2.6 | 7.7 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
2.4 | 7.2 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
2.3 | 11.7 | GO:0098973 | structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
2.3 | 11.5 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
2.1 | 6.3 | GO:0004776 | succinate-CoA ligase activity(GO:0004774) succinate-CoA ligase (ADP-forming) activity(GO:0004775) succinate-CoA ligase (GDP-forming) activity(GO:0004776) |
2.0 | 9.8 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
1.9 | 9.3 | GO:0019863 | IgE binding(GO:0019863) immunoglobulin binding(GO:0019865) |
1.8 | 7.3 | GO:0051380 | norepinephrine binding(GO:0051380) |
1.8 | 5.4 | GO:0043878 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity(GO:0043878) |
1.7 | 5.2 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) IgE receptor activity(GO:0019767) |
1.6 | 3.3 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
1.5 | 4.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
1.5 | 6.2 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
1.5 | 10.6 | GO:0003993 | acid phosphatase activity(GO:0003993) |
1.5 | 12.1 | GO:0031419 | cobalamin binding(GO:0031419) |
1.5 | 4.5 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
1.5 | 7.4 | GO:1990756 | protein binding, bridging involved in substrate recognition for ubiquitination(GO:1990756) |
1.4 | 5.7 | GO:0004903 | growth hormone receptor activity(GO:0004903) |
1.4 | 5.6 | GO:0047611 | acetylspermidine deacetylase activity(GO:0047611) |
1.4 | 4.2 | GO:0003978 | UDP-glucose 4-epimerase activity(GO:0003978) |
1.4 | 5.6 | GO:0008117 | sphinganine-1-phosphate aldolase activity(GO:0008117) |
1.3 | 12.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
1.3 | 9.3 | GO:0000254 | C-4 methylsterol oxidase activity(GO:0000254) |
1.3 | 9.2 | GO:0004962 | endothelin receptor activity(GO:0004962) |
1.3 | 6.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
1.3 | 5.2 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
1.3 | 13.9 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
1.2 | 8.6 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
1.2 | 3.7 | GO:0015086 | cadmium ion transmembrane transporter activity(GO:0015086) |
1.2 | 8.4 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
1.2 | 10.8 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
1.2 | 3.6 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
1.1 | 11.4 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
1.1 | 3.4 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
1.1 | 6.6 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
1.1 | 2.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
1.1 | 4.4 | GO:0070643 | vitamin D 25-hydroxylase activity(GO:0070643) |
1.1 | 5.4 | GO:0001735 | prenylcysteine oxidase activity(GO:0001735) |
1.1 | 12.9 | GO:1904047 | S-adenosyl-L-methionine binding(GO:1904047) |
1.1 | 6.4 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
1.1 | 3.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.1 | 3.2 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
1.1 | 7.4 | GO:1903924 | estradiol binding(GO:1903924) |
1.1 | 4.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
1.0 | 4.0 | GO:0033149 | FFAT motif binding(GO:0033149) |
1.0 | 10.6 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
1.0 | 3.8 | GO:0017064 | fatty acid amide hydrolase activity(GO:0017064) |
0.9 | 2.8 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.9 | 3.6 | GO:0003979 | UDP-glucose 6-dehydrogenase activity(GO:0003979) |
0.9 | 3.5 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.9 | 3.5 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.8 | 11.8 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.8 | 2.5 | GO:0033897 | ribonuclease T2 activity(GO:0033897) |
0.8 | 5.0 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.8 | 4.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.8 | 15.1 | GO:0019211 | phosphatase activator activity(GO:0019211) protein phosphatase activator activity(GO:0072542) |
0.8 | 7.1 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.8 | 11.8 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.8 | 7.6 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.8 | 150.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.7 | 3.0 | GO:0005471 | ATP:ADP antiporter activity(GO:0005471) |
0.7 | 2.2 | GO:0015462 | protein-transmembrane transporting ATPase activity(GO:0015462) |
0.7 | 14.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.7 | 2.9 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.7 | 2.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.7 | 4.3 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.7 | 2.8 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
0.7 | 2.1 | GO:0080132 | fatty acid alpha-hydroxylase activity(GO:0080132) |
0.7 | 4.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.7 | 5.5 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.7 | 5.4 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
0.7 | 12.1 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.7 | 5.9 | GO:0000048 | peptidyltransferase activity(GO:0000048) glutathione hydrolase activity(GO:0036374) |
0.7 | 15.0 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.7 | 8.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.6 | 4.5 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
0.6 | 7.0 | GO:0004309 | exopolyphosphatase activity(GO:0004309) |
0.6 | 6.8 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.6 | 1.9 | GO:0047760 | medium-chain fatty acid-CoA ligase activity(GO:0031956) butyrate-CoA ligase activity(GO:0047760) |
0.6 | 1.8 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.6 | 5.5 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.6 | 2.4 | GO:0031544 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.6 | 7.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.6 | 8.3 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.6 | 1.8 | GO:0004113 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity(GO:0004113) |
0.6 | 26.5 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.6 | 5.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.6 | 6.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.6 | 1.7 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
0.6 | 1.7 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.6 | 2.3 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.6 | 2.3 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.6 | 2.8 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.6 | 7.8 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.6 | 1.7 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.5 | 9.9 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.5 | 2.1 | GO:0008442 | 3-hydroxyisobutyrate dehydrogenase activity(GO:0008442) |
0.5 | 10.6 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.5 | 30.3 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.5 | 4.2 | GO:0015157 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.5 | 3.5 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.5 | 58.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.5 | 10.5 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.5 | 12.4 | GO:0015377 | cation:chloride symporter activity(GO:0015377) potassium:chloride symporter activity(GO:0015379) |
0.5 | 12.9 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.5 | 5.5 | GO:0004568 | chitinase activity(GO:0004568) |
0.5 | 0.5 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
0.5 | 2.4 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
0.5 | 2.4 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.5 | 1.9 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.5 | 7.3 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.4 | 2.7 | GO:0048156 | tau protein binding(GO:0048156) |
0.4 | 3.5 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.4 | 4.0 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.4 | 1.3 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.4 | 2.6 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.4 | 1.7 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.4 | 5.6 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.4 | 8.1 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.4 | 1.3 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
0.4 | 2.1 | GO:0017113 | uracil binding(GO:0002058) pyrimidine nucleobase binding(GO:0002061) dihydropyrimidine dehydrogenase (NADP+) activity(GO:0017113) |
0.4 | 3.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.4 | 7.0 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.4 | 7.8 | GO:0042379 | chemokine activity(GO:0008009) chemokine receptor binding(GO:0042379) |
0.4 | 4.0 | GO:0052650 | alcohol dehydrogenase (NADP+) activity(GO:0008106) NADP-retinol dehydrogenase activity(GO:0052650) |
0.4 | 5.1 | GO:0055102 | phospholipase inhibitor activity(GO:0004859) lipase inhibitor activity(GO:0055102) |
0.4 | 1.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.4 | 1.6 | GO:0004064 | arylesterase activity(GO:0004064) |
0.4 | 1.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.4 | 0.4 | GO:0052813 | phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.4 | 12.0 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.4 | 8.4 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.4 | 20.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.4 | 3.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.4 | 30.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.4 | 1.9 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.4 | 4.1 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.4 | 1.5 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.4 | 1.9 | GO:0039706 | co-receptor binding(GO:0039706) |
0.4 | 1.1 | GO:0047804 | cysteine-S-conjugate beta-lyase activity(GO:0047804) |
0.4 | 4.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.4 | 43.5 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.4 | 3.6 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.4 | 1.1 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.4 | 2.8 | GO:0072518 | Rho-dependent protein serine/threonine kinase activity(GO:0072518) |
0.4 | 3.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.4 | 3.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.3 | 2.4 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.3 | 4.8 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
0.3 | 3.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 3.0 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.3 | 5.0 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.3 | 7.3 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.3 | 4.9 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.3 | 1.3 | GO:0004361 | glutaryl-CoA dehydrogenase activity(GO:0004361) |
0.3 | 1.3 | GO:0005463 | UDP-glucuronic acid transmembrane transporter activity(GO:0005461) UDP-N-acetylgalactosamine transmembrane transporter activity(GO:0005463) |
0.3 | 16.9 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.3 | 3.6 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.3 | 2.3 | GO:0019809 | spermidine binding(GO:0019809) |
0.3 | 23.0 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.3 | 4.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.3 | 1.2 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.3 | 6.5 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.3 | 0.9 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.3 | 16.1 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.3 | 7.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.3 | 7.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.3 | 3.9 | GO:0070035 | ATP-dependent DNA helicase activity(GO:0004003) ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.3 | 1.5 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.3 | 1.2 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
0.3 | 0.9 | GO:0004736 | pyruvate carboxylase activity(GO:0004736) |
0.3 | 2.3 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.3 | 2.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.3 | 1.7 | GO:0008142 | oxysterol binding(GO:0008142) |
0.3 | 3.1 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.3 | 3.6 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.3 | 8.0 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.3 | 1.1 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.3 | 3.2 | GO:0030515 | snoRNA binding(GO:0030515) |
0.3 | 2.4 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.3 | 4.7 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.3 | 2.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.3 | 2.8 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) insulin-like growth factor II binding(GO:0031995) |
0.3 | 3.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.3 | 13.1 | GO:0015485 | cholesterol binding(GO:0015485) |
0.2 | 3.7 | GO:0005123 | death receptor binding(GO:0005123) |
0.2 | 3.0 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 10.9 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.2 | 2.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.2 | 1.9 | GO:0001130 | bacterial-type RNA polymerase transcription factor activity, sequence-specific DNA binding(GO:0001130) bacterial-type RNA polymerase transcriptional repressor activity, sequence-specific DNA binding(GO:0001217) |
0.2 | 6.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 1.0 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.2 | 5.2 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 1.2 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.2 | 9.3 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.2 | 2.8 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.2 | 3.8 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.2 | 2.8 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.2 | 7.3 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.2 | 2.8 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.2 | 0.9 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 6.1 | GO:0045182 | translation regulator activity(GO:0045182) |
0.2 | 3.6 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 11.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 1.5 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.2 | 0.9 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.2 | 6.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 3.7 | GO:0061608 | nuclear import signal receptor activity(GO:0061608) |
0.2 | 3.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 1.9 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.2 | 13.7 | GO:1902936 | phosphatidylinositol bisphosphate binding(GO:1902936) |
0.2 | 10.1 | GO:0043022 | ribosome binding(GO:0043022) |
0.2 | 5.0 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.2 | 0.8 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.2 | 0.8 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 2.5 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 1.0 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 2.5 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.2 | 3.2 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 1.5 | GO:0043394 | glycoprotein binding(GO:0001948) proteoglycan binding(GO:0043394) |
0.2 | 1.3 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.2 | 41.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.2 | 2.0 | GO:0019843 | rRNA binding(GO:0019843) |
0.2 | 2.7 | GO:2001069 | glycogen binding(GO:2001069) |
0.2 | 0.7 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 0.7 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
0.2 | 0.9 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.2 | 1.9 | GO:0052796 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 6.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) phospholipase C activity(GO:0004629) |
0.2 | 4.9 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.2 | 8.5 | GO:0016859 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) cis-trans isomerase activity(GO:0016859) |
0.2 | 1.2 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 0.7 | GO:0101006 | protein histidine phosphatase activity(GO:0101006) |
0.2 | 4.1 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.2 | 20.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 0.8 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 0.8 | GO:0070008 | serine-type carboxypeptidase activity(GO:0004185) serine-type exopeptidase activity(GO:0070008) |
0.2 | 2.4 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.2 | 1.6 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.2 | 0.8 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 0.6 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.2 | 19.4 | GO:0005125 | cytokine activity(GO:0005125) |
0.2 | 1.6 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.2 | 1.6 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.2 | 0.5 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.2 | 0.6 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 3.1 | GO:0005496 | steroid binding(GO:0005496) |
0.1 | 0.7 | GO:0019778 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
0.1 | 1.2 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.1 | 0.9 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 2.3 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.1 | 1.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.9 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 0.8 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.1 | 8.6 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 0.8 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.1 | 1.6 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.1 | 1.9 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.8 | GO:0043914 | NADPH:sulfur oxidoreductase activity(GO:0043914) |
0.1 | 0.5 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 0.9 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.1 | 1.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 3.5 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.4 | GO:0004031 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.1 | 10.2 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.1 | 36.6 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 1.6 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 2.5 | GO:0019955 | cytokine binding(GO:0019955) |
0.1 | 0.6 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.1 | 0.4 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.1 | 2.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 1.6 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 8.1 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 1.5 | GO:0016775 | creatine kinase activity(GO:0004111) phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.1 | 1.4 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 0.9 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 1.3 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.1 | 1.1 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 4.2 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 0.6 | GO:0017171 | serine-type peptidase activity(GO:0008236) serine hydrolase activity(GO:0017171) |
0.1 | 0.4 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 2.3 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 10.9 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 1.0 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.1 | 0.5 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.1 | 0.4 | GO:0002020 | protease binding(GO:0002020) |
0.1 | 7.3 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.8 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.1 | 0.5 | GO:0046592 | polyamine oxidase activity(GO:0046592) |
0.1 | 0.5 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
0.1 | 2.6 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 2.2 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 0.8 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 1.1 | GO:0051117 | ATPase binding(GO:0051117) |
0.1 | 0.8 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 1.3 | GO:0031682 | G-protein gamma-subunit binding(GO:0031682) |
0.1 | 0.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 4.4 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.1 | 1.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 2.8 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 4.1 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 1.7 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 1.0 | GO:0005222 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) intracellular cAMP activated cation channel activity(GO:0005222) intracellular cGMP activated cation channel activity(GO:0005223) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.1 | 1.6 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.5 | GO:0031779 | melanocortin receptor binding(GO:0031779) |
0.1 | 2.9 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 1.8 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.1 | 0.3 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
0.1 | 0.9 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 1.1 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 1.2 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 1.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 3.0 | GO:0005126 | cytokine receptor binding(GO:0005126) |
0.1 | 0.5 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 2.0 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.8 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.5 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 1.0 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.2 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.1 | 6.4 | GO:0042277 | peptide binding(GO:0042277) |
0.1 | 0.7 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 1.4 | GO:0099604 | ligand-gated calcium channel activity(GO:0099604) |
0.1 | 0.4 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.1 | 15.4 | GO:0005198 | structural molecule activity(GO:0005198) |
0.1 | 0.2 | GO:0001635 | adrenomedullin receptor activity(GO:0001605) calcitonin gene-related peptide receptor activity(GO:0001635) |
0.0 | 0.2 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.0 | 0.6 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 10.5 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.6 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.9 | GO:0042805 | actinin binding(GO:0042805) muscle alpha-actinin binding(GO:0051371) alpha-actinin binding(GO:0051393) |
0.0 | 0.9 | GO:0004875 | complement receptor activity(GO:0004875) |
0.0 | 0.5 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.4 | GO:0042562 | hormone binding(GO:0042562) |
0.0 | 0.4 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.0 | 2.6 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.0 | 0.6 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 2.4 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 1.3 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.0 | 0.1 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.6 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.8 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.0 | 1.0 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.0 | 21.1 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.1 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.0 | 0.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 1.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 1.4 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.0 | 0.5 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.0 | 0.1 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.0 | 0.5 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 1.8 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) |
0.0 | 1.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.2 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.2 | GO:0098809 | nitrite reductase activity(GO:0098809) |
0.0 | 0.3 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.2 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.0 | 0.9 | GO:0016209 | antioxidant activity(GO:0016209) |
0.0 | 0.9 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.1 | GO:0000992 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 3 promoter sequence-specific DNA binding(GO:0001006) RNA polymerase III regulatory region DNA binding(GO:0001016) RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
0.0 | 2.4 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.0 | 0.3 | GO:0031267 | small GTPase binding(GO:0031267) |
0.0 | 0.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 0.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.0 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 12.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
1.2 | 2.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
1.1 | 5.5 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.9 | 12.9 | PID ALK2 PATHWAY | ALK2 signaling events |
0.9 | 7.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.8 | 5.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.8 | 4.8 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.8 | 19.7 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.7 | 6.6 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.6 | 6.6 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.6 | 4.0 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.5 | 5.8 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.5 | 6.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.4 | 7.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.4 | 1.7 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.4 | 28.9 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.4 | 16.8 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.4 | 6.3 | PID EPO PATHWAY | EPO signaling pathway |
0.4 | 1.6 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.4 | 4.2 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.4 | 19.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.4 | 5.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.3 | 1.0 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.3 | 3.8 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.3 | 15.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.3 | 3.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.3 | 10.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.3 | 1.5 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.3 | 12.5 | PID PLK1 PATHWAY | PLK1 signaling events |
0.3 | 1.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 3.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 1.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 1.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 2.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 1.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 3.7 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 1.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 1.9 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 3.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 1.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 7.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 1.9 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 5.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 1.6 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 1.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 2.7 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 0.4 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 2.9 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 1.6 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 2.8 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 13.6 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 2.2 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 0.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 3.3 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 3.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 4.0 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 1.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 1.0 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 4.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 1.0 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 0.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 1.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 7.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 1.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.8 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 3.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 1.0 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.0 | 32.1 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
2.3 | 7.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
1.6 | 4.8 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
1.5 | 75.9 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
1.3 | 13.9 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
1.3 | 10.0 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
1.2 | 10.0 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
1.2 | 25.3 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
1.1 | 76.9 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
1.0 | 9.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.9 | 4.7 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.9 | 4.6 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.8 | 5.0 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.8 | 10.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.8 | 8.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.8 | 9.9 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.7 | 15.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.7 | 11.6 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.7 | 6.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.6 | 6.6 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.6 | 6.7 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.5 | 6.6 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.5 | 1.6 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.5 | 4.8 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.5 | 3.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.5 | 8.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.5 | 3.3 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.4 | 2.7 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.4 | 5.2 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.4 | 1.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.4 | 5.6 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.4 | 1.6 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.4 | 2.7 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.4 | 6.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.4 | 5.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.3 | 3.8 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.3 | 9.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.3 | 3.1 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.3 | 2.3 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.3 | 3.0 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.3 | 6.9 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.3 | 1.9 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.3 | 2.9 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.3 | 2.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.3 | 5.6 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.3 | 10.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.3 | 6.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 0.9 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.3 | 0.3 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.3 | 1.4 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.3 | 1.6 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.3 | 2.4 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.3 | 10.8 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.3 | 7.1 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.3 | 7.0 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.3 | 9.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 1.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 3.5 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 7.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 0.9 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.2 | 0.9 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 2.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 3.3 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.2 | 2.2 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.2 | 3.0 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 15.6 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 11.2 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 6.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 2.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.2 | 2.7 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 2.3 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.2 | 1.9 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.2 | 1.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 2.0 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.2 | 2.0 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.2 | 3.4 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 4.4 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.2 | 1.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.2 | 3.0 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 1.0 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.2 | 2.1 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.2 | 0.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.2 | 2.1 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.2 | 0.6 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 1.8 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.1 | 5.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 3.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 1.6 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.1 | 1.7 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 1.7 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.8 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.1 | 2.0 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 3.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 1.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 1.7 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 0.6 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 1.6 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 4.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 1.8 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 2.5 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 1.1 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 4.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 1.4 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 2.0 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 1.1 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 7.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 2.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 1.4 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.1 | 1.3 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 1.3 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 2.0 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 0.9 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 2.6 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 2.1 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 2.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 1.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 0.6 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.1 | 1.6 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 7.8 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
0.1 | 1.1 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.9 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 5.3 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 0.5 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.0 | 0.7 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.4 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.0 | 1.1 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.6 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.5 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.0 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |